Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2009 045 778.0 |
96 | EP file number | EAKZ | 12 19 3597.7 |
97 | EP publication number | EPN | 2599475 |
54 | Designation/title | TI | Pharmazeutische Zusammensetzung mit erwünschter Bioverfügbarkeit |
51 | IPC main class | ICM (ICMV) | A61K 9/00 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/535 (2006.01), A61K 31/5575 (2006.01), A61K 31/542 (2006.01), A61K 45/06 (2006.01), A61K 31/215 (2006.01) |
22 | DE application date | DAT | Mar 13, 2009 |
96 | EP application date | EAT | Mar 13, 2009 |
43 | Date of first publication | OT | Jun 5, 2013 |
| Date of publication of grant | PET | Apr 26, 2017 |
71/73 | Applicant/owner | INH | Novartis AG, Basel, CH |
72 | Inventor | IN | Kabra, Bhagwati P., Euless, TX Texas 76039, US; Carreras, Nuria, 08140 Caldes De Montbui (Barcelona), ES; Cuchi, Mónica, Barcelona, ES; Galán, Francisco Javier, 08329 Teia (Barcelona), ES; Mridvika, 08348 Cabrils (Barcelona), ES; Puig, Elena González, 08013 Barcelona, ES; Jiménez, Nuria, 08005 Barcelona, ES; Martínez, Carmen, 08185 Llicà De Vall (Barcelona), ES |
| Address for service | | Novartis AG, 4002 Basel, CH |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 37117 P Mar 17, 2008
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 111920 P Nov 6, 2008
|
| Due date | FT FG | Mar 31, 2026 Annual fee for the 18th year
Patent fees |
| Patent division in charge | | 44 |
65 | Splitting off in file number | AIAKZ | 20 2009 019 087.0 20 2009 019 114.1 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002599475 Searchable text:
EP000002599475 Original document:
EP000002599475B1 Searchable text:
EP000002599475B1 |
43 | Date of first publication | EVT | Jun 5, 2013 |
| Date of the first transfer into DPMAregister | EREGT | Jul 19, 2013 |
| Date of the (most recent) update in DPMAregister | REGT | Feb 22, 2025 (Show all update days)(Hide all update days)- Feb 22, 2025
- Nov 14, 2024
- Procedures: Opposition procedure, Decision by EPO to maintain patent in full has become final, 12.06.2024: changed
- Oct 10, 2024
- Procedures: Opposition procedure, Decision by EPO to maintain patent in full has become final, 12.06.2024: new
- Procedures: Opposition procedure, Patent maintained in full by EPO, 12.06.2024: new
- May 9, 2024; Feb 24, 2024; Jan 11, 2024; Mar 1, 2023; Mar 1, 2022; Mar 12, 2021; May 14, 2020; Apr 8, 2020; Mar 16, 2020; Aug 13, 2019; Mar 9, 2019; Feb 28, 2019; Mar 9, 2018; Feb 22, 2018; Jun 8, 2017; Apr 28, 2017; Apr 27, 2017; Apr 13, 2017; Aug 2, 2016; May 21, 2016
- Historical data not available for this/these date(s)
- Jul 19, 2013
- Date of the first transfer into DPMAregister
|